Crinetics Pharmaceuticals, Inc.
NASDAQCrinetics Pharmaceuticals heads into the week with its stock having nearly doubled on a massive catalyst — while Wall Street responds by downgrading in unison, creating one of the more striking divergences in recent biotech history. The move is extraordinary by any measure. CRNX closed at $83.53 on July 7, up 99% on the day and 123% on the week. The one-month gain has now reached…
CRNX short interest falls 21.5% in a week to 12.9% of float, as cost to borrow remains subdued at 0.48% annualized.
Snapshot as of 8 Jul 2026
Crinetics Pharmaceuticals heads into the week with its stock having nearly doubled on a massive catalyst — while Wall Street responds by downgrading in unison, creating one of the more striking divergences in recent…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRNX — free to start on ORTEX.
Sign up for free →Open CRNX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CRNX data →